Prevalence and Risk Factors for Secondary Hypertension in Young Adults.
de Freminville JB, Gardini M, Cremer A, Camelli S, Baron S, Bobrie G, Gosse P, Boulestreau R, Gebara N, Doublet J, Dussartre T, Grataloup C, Lorthioir A, Massien C, Madjalian AM, Riancho J, Soulat G, Postel-Vinay N, Azizi M, Rance B, Amar L.
Hypertension. 2024 Nov;81(11):2340-2349. doi: 10.1161/HYPERTENSIONAHA.124.22753. Epub 2024 Sep 19.
Clinicopathological Study of Chronic Kidney Disease of Unknown Etiology in Odisha.
Parida S, Das S, Kar A, Routray RK.
J Assoc Physicians India. 2022 Oct;70(10):11-12. doi: 10.5005/japi-11001-0115.
Association of hypertension and hypokalemia with Cushing's syndrome caused by ectopic ACTH secretion: a series of 58 cases.
Torpy DJ, Mullen N, Ilias I, Nieman LK.
Ann N Y Acad Sci. 2002 Sep;970:134-44. doi: 10.1111/j.1749-6632.2002.tb04419.x.
Hypertension and the kidney: perspectives on the relationship of kidney disease and cardiovascular disease.
Weir MR.
Clin J Am Soc Nephrol. 2009 Dec;4(12):2045-50. doi: 10.2215/CJN.03050509. Epub 2009 Jul 16.
[Familial hyperaldosteronism].
Spoto B, Furlò G, Gervasi A, Bresolin G, Zoccali C.
G Ital Nefrol. 2004 Mar-Apr;21(2):139-43.
Arterial hypertension of infrequent cause.
Rosales-Castillo A, Bustos-Merlo A.
Hipertens Riesgo Vasc. 2022 Apr-Jun;39(2):92-94. doi: 10.1016/j.hipert.2021.09.002. Epub 2021 Oct 13.
Kidney-specific WNK1 amplifies kidney tubule responsiveness to potassium via WNK body condensates.
Boyd-Shiwarski CR, Beacham RT, Lashway JA, Querry KE, Griffiths SE, Shiwarski DJ, Knoell SA, Nguyen NH, Nkashama LJ, Valladares MN, Bandaru A, Marciszyn AL, Franks J, Sullivan M, Watkins SC, Rodan AR, Huang CL, Stocker SD, Kashlan OB, Subramanya AR.
J Clin Invest. 2025 Jun 10;135(15):e188792. doi: 10.1172/JCI188792. eCollection 2025 Aug 1.
Peritoneal dialysis-related infections in elderly patients.
Sakurada T, Miyazaki M, Nakayama M, Ito Y.
Clin Exp Nephrol. 2024 Nov;28(11):1065-1074. doi: 10.1007/s10157-024-02531-5. Epub 2024 Jun 25.
Virtual screening and biological evaluation to identify pharmaceuticals potentially causing hypertension and hypokalemia by inhibiting steroid 11beta-hydroxylase.
Jäger MC, Kędzierski J, Gell V, Wey T, Kollár J, Winter DV, Schuster D, Smieško M, Odermatt A.
Toxicol Appl Pharmacol. 2023 Sep 15;475:116638. doi: 10.1016/j.taap.2023.116638. Epub 2023 Jul 26.
Neuroblastoma accompanied by hyperaldosteronism.
Gulleroglu K, Bayrakci U, Tulgar Kinik S, Uslu N, Ok Atilgan A, Sarialioglu F, Baskin E.
J Renal Inj Prev. 2014 Jul 1;3(3):79-82. doi: 10.12861/jrip.2014.23. eCollection 2014.
